Literature DB >> 16095221

[Acute non-herpetic viral encephalitis of juvenile onset: analysis of 11 cases based on initial clinical symptoms].

Hiroshi Kataoka1, Nobuo Kohara, Wakiro Sato, Manabu Sakaguchi, Michi Kawamoto, Shinn Takano.   

Abstract

We investigated clinical features of juvenile patients presenting non-herpetic viral acute encephalitis (4 men and 7 women, aged of onset; 23.7 +/- 3.3 years) without malignancy and immunodeficiency. We divided the patients into two groups according to initial neurological symptoms: psychiatric symptoms mimicking schizophrenia (group P, n=5), seizure (group S, n=6), and compared clinical manifestations among the two groups. Symptoms frequently seen in initial phase of the illness were neck stiffness (4 cases, 36%), involuntary movement (7 cases, 64%) and convulsion (8 cases, 73%). There were no significant difference among the groups except seizure. Patients in group P had more CSF cells and CSF lymphocytes compared with other groups (p < 0.05 and p < 0.01, respectively). Abnormal intensities in T2-weighted magnetic resonance images were found in 4 cases (36%). The term from the onset to leaving hospital of group P (213 +/- 227 days) was longer than that of group S (98 +/- 85 days), although it did not reach a significant difference. These findings indicate that juvenile acute non-herpetic encephalitis initially presenting psychiatric symptoms was serious and had relatively poor prognosis.

Entities:  

Mesh:

Year:  2005        PMID: 16095221

Source DB:  PubMed          Journal:  No To Shinkei        ISSN: 0006-8969


  2 in total

1.  Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.

Authors:  T Iizuka; F Sakai; T Ide; T Monzen; S Yoshii; M Iigaya; K Suzuki; D R Lynch; N Suzuki; T Hata; J Dalmau
Journal:  Neurology       Date:  2007-09-26       Impact factor: 9.910

Review 2.  Molecular Pathogenesis of Anti-NMDAR Encephalitis.

Authors:  Hao Ding; Zhihong Jian; Creed M Stary; Wei Yi; Xiaoxing Xiong
Journal:  Biomed Res Int       Date:  2015-06-28       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.